The Current Ratio as of December 2024 (TTM) for Acer Therapeutics Inc. (ACER) is 0.10

According to Acer Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.10. This represents a change of -37.84% compared to the average of 0.16 of the last 4 quarters.

Acer Therapeutics Inc. (ACER) Historical Current Ratio (quarterly & annually)

How has ACER Current Ratio performed in the past?

The mean historical Current Ratio of Acer Therapeutics Inc. over the last ten years is 3.96. The current 0.10 Current Ratio has changed 151.38% with respect to the historical average. Over the past ten years (40 quarters), ACER's Current Ratio was at its highest in in the September 2018 quarter at 21.96. The Current Ratio was at its lowest in in the September 2023 quarter at 0.10.

Acer Therapeutics Inc. (ACER) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Acer Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Acer Therapeutics Inc. (ACER) Average Current Ratio

How has ACER Current Ratio performed in the past?

The current Current Ratio of Acer Therapeutics Inc. (ACER) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Acer Therapeutics Inc. (ACER) Current Ratio vs. Peers

How is ACER’s Current Ratio compared to its peers?

Acer Therapeutics Inc.’s Current Ratio is less than NRx Pharmaceuticals, Inc. (0), less than Pasithea Therapeutics Corp. (0.20), less than SAB Biotherapeutics, Inc. (14.81), less than Lexaria Bioscience Corp. (3.69), less than Navidea Biopharmaceuticals, Inc. (7.18), less than ZyVersa Therapeutics, Inc. (0.56), less than Biodexa Pharmaceuticals Plc (33.83), less than Oncorus, Inc. (2.16), less than Kiromic BioPharma, Inc. (1.74), less than YS Biopharma Co., Ltd. (0.22), less than BiomX Inc. (0.94), less than Avenue Therapeutics, Inc. (3.17), less than Hoth Therapeutics, Inc. (2.70), less than Revelation Biosciences, Inc. (10.16), less than NeuroBo Pharmaceuticals, Inc. (1.64), less than Virax Biolabs Group Limited (2.41), less than null (25.94),

Build a custom stock screener for Acer Therapeutics Inc. (ACER) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acer Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Acer Therapeutics Inc. (ACER) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Acer Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.